| Document Date: 2014-12-10 12:20:46
Open Document File Size: 273,38 KBShare Result on Facebook
City Philadelphia / / Company Perle Biosciences / Sanofi / Perle Bioscience Inc. / / Continent Europe / / Country United States / / Event FDA Phase / / Facility Medical College of Pennsylvania / When MCP Hospital / Yale University / Drexel College of Medicine / / MedicalCondition disease / sudden injury / diabetes / injury / / MedicalTreatment dialysis / / Organization Drexel College of Medicine / FDA / Hahnemann Medical School / Medical College of Pennsylvania / MCP Hospital / Yale University / / Person Frederick Banting / Cara Murphy / Claresa Levetan / / Position Chief Scientific Officer / Chief / / Product Cyclosporine / Lansoprazole / US / / ProvinceOrState Pennsylvania / / Technology alpha / human genome / dialysis / / URL www.PerleBioscience.com / http /
SocialTag |
Diabetes Awareness Month Practical Cure Interview Series: Cyclosporine Lansoprazole The next interview in our Practical Cure series is with Dr. Levetan from Perle Biosciences. We identified the Cyclosporine Lansoprazole